Contact us


Safety and Efficacy Study of CC-486 With MK-3475 to Treat Locally Advanced or Metastatic Non-small Cell Lung Cancer

A Phase 2 Multicenter, Randomized, Placebo Controlled Study to Assess the Safety and Efficacy of CC-486 (Oral Azacitidine) in Combination With MK-3475 Versus MK-3475 Alone in Subjects With Previously Treated Locally Advanced and/or Metastatic Non-small Cell Lung Cancer.

For more information, please visit

Patient Population Investigational Product(s) Phase Status
NSCLC CC-486 and Pembrolizumab II Open and Accruing